Pulse Biosciences

Pulse Biosciences

PLSE· Manufacturing· Fiscal year ends in December

CEO pay in FY2025Stock -21.1% in FY2025

Paul A. LaViolette is the CEO of Pulse Biosciences and was paid $7.4M in FY2025 (Dec).

Pay$100 in the stock at the end of FY21 → $93
CEO pay is from each Pulse Biosciences proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Executives6

See all
  1. 1Paul A. LaVioletteFY2025
  2. 2Jon SkinnerFY2025
  3. 3Darrin R. UeckerFY2025
  4. 4Kevin P. DanahyFY2025
  5. 5Burke T. BarrettFY2025
  6. 6Mitchell E. LevinsonFY2025

Named executives and their total pay, from the Summary Compensation Table of the latest proxy.

Pay

See all

Pulse Biosciences paid its 6 named executives $12.0M in total in FY2025 (Dec). CEO Paul A. LaViolette was paid $7.4M of that.

Name
Paul A. LaVioletteChief Executive Officer and Co-Chairman
Jon SkinnerChief Financial Officer
Darrin R. UeckerChief Technology Officer and Director
Kevin P. DanahyFormer Chief Commercial Officer
Burke T. BarrettFormer Chief Executive Officer and Former Director
Mitchell E. LevinsonFormer Chief Strategy Officer and Former Director

of each named executive, from the Summary Compensation Table of each proxy.

Peers

No disclosed peer group

No proxy on file names a pay peer group for Pulse Biosciences. The peer group comes from the proxy statement, so it shows here when a proxy read has it.

Board3

See all
  • Manmeet S. SoniLead independent director · 8 yr on the boardIndependentAudit (Chair), Compensation (Chair), Nominating and Corporate Governance (Chair), Strategic Advisory—Paid as an executive
  • Mahkam Zanganeh, D.D.S.Director · 8 yr on the boardIndependentStrategic Advisory—Paid as an executive
  • Maria SainzDirector · 0 yr on the boardIndependentAudit—Paid as an executive

The board of the latest proxy (FY2025).

Activity

  1. Pay
    Pulse Biosciences Former Chief Strategy Officer and Former Director pay fell 100% to $0. The stock rose 42% in FY2024 (Dec).
    DEF 14A
  2. Pay
    Pulse Biosciences Former Chief Commercial Officer pay fell 56% to $854.6K. The stock fell 21% in FY2025 (Dec).
    DEF 14A
  3. Pay
    Pulse Biosciences Former Chief Commercial Officer pay fell 67% to $1.9M. The stock rose 42% in FY2024 (Dec).
    DEF 14A
  4. Pay
    Pulse Biosciences CTO pay rose 41% to $869.9K. The stock fell 21% in FY2025 (Dec).
    DEF 14A
  5. Pay
    Pulse Biosciences CTO pay fell 89% to $616.4K. The stock rose 42% in FY2024 (Dec).
    DEF 14A
  6. Pay
    Pulse Biosciences Former CEO pay fell 100% to $0. The stock fell 21% in FY2025 (Dec).
    DEF 14A
  7. Board
    Maria Sainz joined the board of Pulse Biosciences. Maria Sainz now sits on 2 public boards.
    3
  8. Pay
    Pulse Biosciences Former Chief Strategy Officer and Former Director pay rose 369% to $1.7M. The stock rose 342% in FY2023 (Dec).
    DEF 14A
  9. Pay
    Pulse Biosciences Former Chief Commercial Officer pay rose 274% to $5.9M. The stock rose 342% in FY2023 (Dec).
    DEF 14A
  10. Pay
    Pulse Biosciences CTO pay rose 1,006% to $5.4M. The stock rose 342% in FY2023 (Dec).
    DEF 14A

Filings6

See all
Proxy statementDEF 14AMay 11, 2026FY2025
Annual report10-KFeb 19, 2026FY2025
Proxy statementDEF 14ASep 3, 2025—
Annual report10-KMar 31, 2025FY2024
Proxy statementDEF 14AApr 23, 2024FY2023
Annual report10-KMar 28, 2024FY2023
For the press:Download CSVDownload PNGHow to use our data